Petri Bio Inc.
Torrance, CA
- UEI
- C1DCLGZZ3YL1
- CAGE
- 8FJ82
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 370 Amapola Ave #100, Torrance, CA 90501, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Engineered microbial therapeutics for methionine restriction treatment of heritable forms of glioma. | National Cancer Institute | $355,000 | |
| Live microbial therapeutics: an enhanced treatment paradigm for classical homocystinuria - project summary the goal of… | National Institute of Child Health and Human Development | $2,170,314 | |
| Live microbial therapeutics for enzyme replacement therapy against homocystinuria - project summary the goal of this… | National Institute of Child Health and Human Development | $416,931 |
About Petri Bio Inc.
Petri Bio Inc. is a for-profit corporation registered to receive federal awards since November 2019. The company specializes in developing innovative microbial therapeutics for the treatment of rare genetic disorders and cancers. Their work primarily focuses on engineering bacterial strains to modulate metabolic pathways and serve as expression vectors for therapeutic proteins. Petri Bio Inc. has received both federal contract and grant awards, demonstrating their expertise in cutting-edge biotechnology research and development.
In February 2023, Petri Bio Inc. was awarded a $355,000 Firm Fixed Price contract by the National Cancer Institute (NCI) under the Small Business Innovation Research (SBIR) Phase I program. This contract, set aside for small businesses, aims to develop engineered microbial therapeutics for treating heritable forms of glioma, a type of brain cancer. The project focuses on demonstrating technical feasibility and proof-of-concept for this therapeutic technology, which involves using engineered microbes for methionine restriction treatment. This award is part of a larger NCI SBIR Innovative Concept Award program seeking proposals for developing therapeutic, device, or diagnostic technologies for pediatric and rare cancers.
Petri Bio Inc. has also received two significant federal grant awards from the National Institute of Child Health and Human Development. The first, awarded in September 2021, is an SBIR Phase I grant (R43HD107885) for developing a synthetic live bacterial therapeutic for homocystinuria (HCU), a rare metabolic disorder. The project aims to engineer bacterial strains capable of breaking down methionine in the gut to reduce systemic levels of homocysteine. The second grant, awarded in May 2022, is an SBIR Phase II grant (R44HD107885) that builds upon the Phase I research. This project focuses on optimizing the engineered bacterial strains, developing commercial-scale fermentation methods, and conducting safety and efficacy testing in animal models of HCU. Both grants demonstrate Petri Bio Inc.'s commitment to developing innovative treatments for rare genetic disorders using their proprietary microbial therapeutic platform.
Quick answers
What is Petri Bio Inc.'s UEI?
Petri Bio Inc.'s Unique Entity ID (UEI) in SAM.gov is C1DCLGZZ3YL1.
What is Petri Bio Inc.'s CAGE code?
Petri Bio Inc.'s CAGE code is 8FJ82.
What is Petri Bio Inc.'s primary NAICS code?
Petri Bio Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Petri Bio Inc. located?
Petri Bio Inc.'s physical address in SAM.gov is 370 Amapola Ave #100, Torrance, CA 90501, USA.
Is Petri Bio Inc. registered in SAM.gov?
Yes. Petri Bio Inc.'s SAM.gov registration is active through December 26, 2026.
What is Petri Bio Inc.'s most recent federal award?
Petri Bio Inc.'s most recent federal contract award is Engineered microbial therapeutics for methionine restriction treatment of heritable forms of glioma (75N91023C00009), from National Cancer Institute, on February 28, 2023.
On GovTribe
See Petri Bio Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors